Cargando…
Intracameral bevacizumab administered for non-small cell lung cancer metastasis to iris
Ocular iris metastasis from lung cancer is uncommon. We report a patient with metastatic non-small cell lung cancer who was found to have a metastatic lesion to the iris. Local therapy for pain control and vision loss was administered with intracameral bevacizumab. Complete resolution of pain, impro...
Autores principales: | Schell, Jonathan C., Koenig, Steven B., Bastin, Kenneth, Wirostko, William J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PAGEPress Publications
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3981238/ https://www.ncbi.nlm.nih.gov/pubmed/24765300 http://dx.doi.org/10.4081/cp.2011.e39 |
Ejemplares similares
-
Non-small cell lung cancer with iris metastasis controlled with osimertinib and monthly intravitreal bevacizumab
por: Wong, Margaret, et al.
Publicado: (2022) -
A Case Report of Intravitreal Bevacizumab for Iris Metastasis of Small Cell Lung Carcinoma with Neovascular Glaucoma
por: Hidaka, Takako, et al.
Publicado: (2018) -
Efficacy and Safety of Intracameral Bevacizumab for Treatment of Neovascular Glaucoma
por: Ha, Jun Young, et al.
Publicado: (2017) -
Unilateral acute iris depigmentation and transillumination after glaucoma surgery with mitomycin application and intracameral moxifloxacin
por: Sánchez-Sánchez, Carmen, et al.
Publicado: (2020) -
Small-cell lung carcinoma metastasis to the iris – case presentation
por: Nikratowicz, Danuta, et al.
Publicado: (2013)